No Evidence of PGRN or MAPT Gene Dosage Alterations in a Collection of Patients with Frontotemporal Lobar Degeneration

BACKGROUND/AIMS: Alterations in gene dosage have recently been associated with neurodegenerative disorders, such as Alzheimer's disease and Parkinson's disease, and deletions of the progranulin (PGRN) locus were recently described in patients with frontotemporal lobar degeneration (FTLD)....

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Dement Geriatr Cogn Disord
Autors principals: Skoglund, Lena, Ingvast, Sofie, Matsui, Toshifumi, Freeman, Stefanie H., Frosch, Matthew P., Brundin, Rosemarie, Giedraitis, Vilmantas, Growdon, John H., Hyman, Bradley T., Lannfelt, Lars, Ingelsson, Martin, Glaser, Anna
Format: Artigo
Idioma:Inglês
Publicat: S. Karger AG 2009
Matèries:
Original Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7077072/
https://ncbi.nlm.nih.gov/pubmed/19940479
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000260046
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars